IP Library › Granted Patent US 10,183,983
Granted Patent B2
US 10,183,983 · App. 15/471,725 · Granted Jan 22, 2019

Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof

Inventors: Peter Pechan (Bridgewater, NJ); Jeffery Ardinger (Bridgewater, NJ); Hillard Rubin (Bridgewater, NJ); Samuel Wadsworth (Shrewsbury, MA); Abraham Scaria (Framingham, MA)
Assignee: GENZYME CORPORATION
C07K14/71A61K38/00C07K2319/30C07K2319/70C12N2510/02C12N2750/14143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,183,983
App. No.
15/471,725
Granted
Jan 22, 2019
Kind
B2
Abstract

The present provides fusion proteins comprising PDGF and VEGF binding portions, and recombinant viral particles encoding the fusion proteins. Compositions comprising the fusion proteins and viral particles as well as methods of using the same are also provided.

Claims (8)

1. A nucleic acid encoding a fusion protein wherein the fusion protein comprises (a) an extracellular portion of a PDGF receptor beta (PDGFRβ) comprising Ig-like domains D1-D3, (b) an extracellular portion of a VEGF receptor 1 (FLT-1) comprising an Ig-like domain D2, and (c) a multimerization domain, wherein the fusion proteins binds to a PDGF and a VEGF, and the fusion protein is arranged from N-terminus to C-terminus in the following order: (a), (b) and (c), and wherein the fusion protein does not comprise an Ig-like domain D3 of a VEGFR2.

2. A host cell comprising the nucleic acid of claim 1 .

3. A method of producing a fusion protein, comprising culturing a host cell comprising the nucleic acid of claim 1 under a condition that produces the fusion protein, and recovering the fusion protein produced by the host cell.

4. The method of claim 3 , wherein the host cell is a mammalian cell.

5. A vector comprising the nucleic acid of claim 1 .

6. The vector of claim 5 , which is a viral vector.

7. The vector of claim 6 , wherein the viral vector is a recombinant adeno-associated virus vector (rAAV).

8. The vector of claim 7 , wherein the rAAV vector comprises an ITR of AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAVrh8, or AAVrh10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: PECHAN, PETER; ARDINGER, JEFFERY; RUBIN, HILLARD; WADSWORTH, SAMUEL; SCARIA, ABRAHAM
To: GENZYME CORPORATION
Reel/Frame 048596/0789 →
Continuity (3)
Division 14210354 · Mar 13, 2014
Provisional Application 61780914 · Mar 13, 2013
Related Publication 20170342127A1 · Nov 30, 2017
Cited By (2)
US 12,514,904 US 12,514,905